The news of a safe, effective vaccine has been a rare bright spot during the yearlong fight against the coronavirus. Two pharmaceutical companies, Pfizer and Moderna, are racing toward emergency authorization for their vaccines, both of which boast an efficacy rate of more than 94 percent. That authorization could come as soon as a few days from now, and the first vaccinations could begin later this month.
A line for the vaccine is already forming, but plenty of questions remain. Recently, the nonprofit Math for America, a New York-based organization for math and science teachers, hosted an information-rich webinar about the coronavirus and the mechanics of developing effective vaccines with Dr. Florian Krammer, a professor of vaccinology at the Icahn School of Medicine at Mount Sinai in New York, who has amassed a large Twitter following in recent months for his discussions on the science of vaccines.
The Flexible Learning Strategies for Out of School Children programme is a UNESCO initiative with the aim of supporting inclusive and quality education for every child in the region. Our goal is to reach the remaining and most vulnerable 5% of children with no access to education in the region and support quality improvements in learning for every child.
The contents, views and opinions expressed in the article on this website are those of the authors and speakers and do not necessarily reflect or represent the views and opinions held by UNESCO.
If you find that your content is being used incorrectly, please contact us at firstname.lastname@example.org. Any infringement was not done on purpose and will be rectified to all parties satisfaction.